Jump to Navigation
Trends and Sentiments
Comments and Analysis
VW Settles Dieselgate For $15 Billion, But More Shoes To...
20 Years Ago, 'The Nutty Professor' Brought...
Keep Calm And Your Portfolio Will Carry On
LA-Based Thrive Market Takes On The USDA To Redefine Food...
All Of 'Game Of Thrones' Season 6 In Under Two...
The 18 CPG Breakthrough Innovation Winners
2016's Breakthrough Consumer Packaged Goods And How...
Lending Club plans layoffs, discloses loans to former CEO...
Blue Shield faces new criticism of shortchanging...
Simon Ramo, TRW co-founder who shaped California...
Technology Leads Week With 5 IPO filings; 5 More Added To Calendar
8 U.S. IPOs Planned For The Week
IPO Preview: Cempra Holdings
2 Life Sciences IPOs Debut Below Target
Caesars Stands Out In A Busy IPO Week With Strong Returns
Trius Therapeutics: The Calm Before The Storm
2012 Biotech IPOs: Age Of The Dreamers?
2 Promising Biopharma Companies To Examine
Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured
Companies That Can Mend The Biotech Market: Stephen Brozak
Cempra's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Cempra Management Discusses Toyama Exclusive Agreement Conference (Transcript)
Cempra's CEO Presents at BARDA Contract Award Conference (Transcript)
Can Cempra Beat The Superbugs?
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Cempra's CEO Discusses Q2 2013 Results - Earnings Call Transcript
Cempra's CEO Discusses Q3 2013 Results - Earnings Call Transcript
This Antibiotic Play May Be The Trius Of 2014
Cempra Holdings Hosts Solithromycin and Taksta Clinical Update Conference Call (Transcript)
Do Away With The Pill-A-Day Biotech Model: Steve Brozak
Cempra: Safety Results Solidifying Market Position
Cempra's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Promising Biotechs Target New Ways To Kill Bad Bugs: Venture Capitalist Dennis Purcell
Cempra's CEO Discusses Q1 2014 Results - Earnings Call Transcript
BERNANKE: The UK faces years of uncertainty and...
We now know the average billionaire is a 63-year-...
EUR/GBP: 1.2078 USD/EUR: 1.1050 JPY/USD: 102.7210
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions